In this episode of Engaging Alternatives Spotlight,  Elana Margulies-Snyderman, Director, Publications, speaks with Christina Ansted and Michael Janes, Senior Managing Partners at RCP Ventures, a Cambridge, Massachusetts-based venture capital firm that invests in biotech and therapeutics. They share the outlook for VC investing in those industries, including the greatest opportunities and challenges. They also discuss how the firm integrates ESG, DEI and more.